Crossmark

ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?

Published Online: 2022-01-21

Published Print: 2022-05

Authors

Morrison, Steven https://orcid.org/0000-0003-0681-696X
Zager, Jonathan S.

Vetto, John
License Information

Text and Data Mining valid from 2022-01-21

Version of Record valid from 2022-01-21
More Information

Article History

Received: 22 November 2021

Accepted: 22 November 2021

First Online: 21 January 2022

Disclosures

: JSZ research funding from Amgen, Castle Biosciences, Delcath Systems, Novartis, Provectus and Philogen; medical advisory board for Delcath Systems, speakers’ bureau for Sun Pharma, Pfizer, and consultant for Merck, Sanofi/Regeneron, Amgen, Castle Biosciences. JTV speaker for Castle Biosciences.

Document is current